An Israeli company has developed a connected cuff that could offer a non-drug alternative for relieving migraines. Already licensed in the United States, a new study has shown an efficacy of around 60% in patients with chronic migraines.
Finally, here is an effective, non-drug treatment for migraines, according to a study published in the journal . Usually, people with must juggle between classic painkillers, often ineffective, and preventive treatment with side effects that can be difficult to bear. Israeli firm Theranica offers alternative in the form of a connected armband called Nerivio.
The device works through a process called remote electrical neuromodulation. Theof the arm are stimulated by electrical impulses to trigger the conditioned modulation of the , a mechanism by which pain is inhibited by more severe pain elsewhere in the body. The remote control makes it possible to achieve this effect thanks to a painless.
Effective two-hour treatment in 60% of patients
The study tested the device on 91 people with(CCQ), in other words crises of 15 days a month for at least three months. 59.3% of patients saw a decrease in pain after two hours of treatment, and 20.9% saw the pain disappear completely. Of these, 64.4% were still relieved after 24 hours. The device was also successful in eliminating nausea, vomiting, photophobia, and phonophobia in 40-50% of patients who reported these .
This study is performed on patients with chronic migraines, but Theranica says Nerivio is suitable for all. The cuff has already been cleared by the United States Medicines Agency ( ) and patients can choose the intensity of treatment via a on their smartphone (iOS and Android). Finally, it should be noted that an armband is limited to 12 treatments of 45 minutes and that the firm has not communicated on a possible launch in France.